ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cyclo-(Phe-Tyr) reduces cerebral ischemia/reperfusion-induced blood-brain barrier dysfunction through regulation of autophagy

Liang, Jiayin; Cai, Jiale; Zhang, Yutong; Xie, Meixia; Li, Xiaoshi; Hu, Tao; Liang, Shengwang; Xian, Minghua*; Wang, Shumei*广东药学院
Food & Function2022-11-28DOI: 10.1039/d2fo02367a
5被引18阅读
引用收藏
分享

摘要

Cerebral ischemia/reperfusion (I/R) injury is the result of ischemic stroke, a serious threat to public health. I/R injury can damage the blood-brain barrier (BBB), adversely affecting the brain environment and aggravating the injury. Cyclo-(Phe-Tyr) (sparganin C, SC) is a small molecule derived from the Chinese yam Dioscorea opposita Thunb. or Sparganii rhizoma. In our previous study, SC mitigates I/R injury both in vivo and in vitro through the action of JUNB and SOX5. However, the exact pharmacological effects of SC on BBB protection after an I/R injury remain unclear. We constructed a rat model of middle cerebral artery occlusion-reperfusion (MCAO/R) injury to evaluate the therapeutic actions of SC, and the integrity of the BBB was evaluated by ELISA, western blotting, and Evans blue staining. It was found that SC significantly reduced the amount of Evans blue staining in the brain, inhibited the expression of inflammatory factors IL-6, IL-1 beta, IL-17, IL-23, and TNF-alpha as well as TIPM1/MMP proteins, and promoted the expression of the tight junction proteins occludin, ZO-1, and claudin-5. SC was found to inhibit the excess autophagy induced by I/R injury to protect BBB integrity through the PI3K/AKT/mTOR pathway, and the PI3K inhibitor LY294002 significantly reduced the SC-mediated protection. Overall, this is the first demonstration of the alleviation of BBB damage caused by I/R injury by SC and suggests a potential treatment for the effects of an ischemic stroke.

学科与关键词

关键词
DOUBLE-EDGED-SWORDSTROKEINJURY
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Food & Function
发表日期
2022-11-28
卷期
第 13 卷, 第 23 期
页码
12278-12290
DOI
10.1039/d2fo02367a
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82004086, 81473413, 81274060, 81773884]; National Major Scientific and Technological Special Project for "Significant New Drugs Development" during the Thirteenth Five-year Plan Period [2017ZX09301077]; Science and Technology Plan Project of Guangzhou [201803010115]; special funds for the Cultivation of Guangdong College Students' Scientific and Technological Innovation ("Climbing Program" Special Funds) [pdjh2022b0271]; Key Unit of Chinese Medicine Digitalization Quality Evaluation of State Administration of Traditional Chinese Medicine

作者

  • L

    Liang, Jiayin (第一作者)

    guangdong pharmaceut univ

  • C

    Cai, Jiale

    guangdong pharmaceut univ

查看全部 9 位作者收起作者
  • Z

    Zhang, Yutong

    guangdong pharmaceut univ

  • X

    Xie, Meixia

    guangdong pharmaceut univ

  • L

    Li, Xiaoshi

  • H

    Hu, Tao

    guangdong pharmaceut univ

  • L

    Liang, Shengwang

    guangdong pharmaceut univ

  • X

    Xian, Minghua (通讯)

    guangdong pharmaceut univ

  • W

    Wang, Shumei (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417